National Forensic Service, Yang-Chun Gu, Seoul, South Korea.
Forensic Sci Int. 2012 Jun 10;219(1-3):265-71. doi: 10.1016/j.forsciint.2012.01.016. Epub 2012 Jan 30.
We described the findings of a study into the post-mortem redistribution (PMR) of 76 drugs found in 129 drug-related cases between 2006 and 2009. Seventy six drugs (psychotropic drugs (n=14), antidepressants (n=9), sedatives (n=6) and so on) were simultaneously quantified in cardiac and peripheral blood by gas chromatography-mass spectrometry (GC/MS) or liquid chromatography-tandem mass spectrometry (LC/MS/MS). The absence, possibility or presence of PMR of drugs was determined according to the ratios of cardiac to femoral blood concentrations (C/P ratios). Proxyphylline (C/P ratio: 0.85) showed no PMR; carbamazepine was not subject to PMR; a potential for PMR of lorazepam and mirtrazapine cannot be excluded; chlordiazepoxide is subject to PMR; acetaminophen and alprazolam exhibit minimal PMR; amitriptyline and benztropine exhibit PMR. Codeine (C/P ratio: 4.9), zolpidem (C/P ratio: 3.74), chlorpromazine (C/P ratio: 2.97), fluoxetine (C/P ratio: 2.83) and propranolol (C/P ratio: 2.72) had the largest C/P ratios. Postmortem drug concentrations showed variations depending on sampling sites and characteristics of the drugs. It is continuously necessary to analyze commonly used or abused drugs in simultaneously collected cardiac and peripheral blood to establish significant reference values for PMR. These findings can be used to reach a conclusion about the cause and manner of death.
我们描述了一项研究的结果,该研究涉及 2006 年至 2009 年间 129 例与药物相关的案例中 76 种药物的死后再分布(PMR)。通过气相色谱-质谱联用(GC/MS)或液相色谱-串联质谱(LC/MS/MS),同时对心脏和外周血中的 76 种药物(精神药物(n=14)、抗抑郁药(n=9)、镇静剂(n=6)等)进行定量分析。根据心脏与股动脉血浓度比(C/P 比值)确定药物是否存在 PMR、PMR 的可能性或 PMR 的存在。可可碱(C/P 比值:0.85)没有 PMR;卡马西平不受 PMR 影响;氯氮卓可能发生 PMR;对乙酰氨基酚和阿普唑仑的 PMR 发生率较低;阿米替林和苯海索发生 PMR。可待因(C/P 比值:4.9)、唑吡坦(C/P 比值:3.74)、氯丙嗪(C/P 比值:2.97)、氟西汀(C/P 比值:2.83)和普萘洛尔(C/P 比值:2.72)的 C/P 比值最大。死后药物浓度的变化取决于采样部位和药物的特性。因此,有必要对心脏和外周血中同时采集的常用药物或滥用药物进行分析,以建立 PMR 的显著参考值。这些发现可用于推断死因和死亡方式。